Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Oxford Biomedical Research in February, 2021 for $99,203.0 USD from the U.S. Department of Agriculture. | SBIR | 2021-00683 | Phase I | 99,203 | February 26, 2021 | |||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research in September, 2017 for $214,396.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM122129-01A1 | Phase I | 214,396 | September 20, 2017 | |||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research in January, 2017 for $146,094.0 USD from the U.S. Department of Defense. | SBIR | H92222-17-P-0007 | Phase I | 146,094 | January 4, 2017 | |||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research in June, 2017 for $99,872.0 USD from the U.S. Department of Agriculture. | SBIR | 2017-33610-26653 | Phase I | 99,872 | June 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $410,915.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44ES0800009 | Phase II | 410,915 | ||||||||
A STTR Phase I contract was awarded to Oxford Biomedical Research for $85,395.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41ES013004-01A1 | Phase I | 85,395 | ||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $496,014.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44AG091658-02A1 | Phase II | 496,014 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $96,484.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA086699-01A2 | Phase I | 96,484 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research from the U.S. Department of Health & Human Services. | SBIR | 9R44AG091658-02A1 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $85,395.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41ES013004-01A1 | Phase I | 85,395 | ||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $710,033.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44ES012277-02 | Phase II | 710,033 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research from the U.S. Department of Health & Human Services. | SBIR | N44ES005448-009 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research from the U.S. Department of Health & Human Services. | SBIR | 2R44ES012277-02 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $138,131.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44ES005448-009 | Phase II | 138,131 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research from the U.S. Department of Health & Human Services. | SBIR | N44ES005448-006 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44ES005448-006 | Phase II | 150,000 | ||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $35,763.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43ES015470-002 | Phase I | 35,763 | ||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $293,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 293,994 | |||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $134,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 134,000 | |||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $197,185.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 197,185 | |||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $99,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 99,000 | |||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research from the U.S. Department of Health & Human Services. | SBIR | Phase I | 0 | |||||||||
A SBIR Phase I contract was awarded to Oxford Biomedical Research for $98,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 98,000 | |||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $280,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 280,000 | |||||||||
A SBIR Phase II contract was awarded to Oxford Biomedical Research for $224,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 224,000 |